Form D · Biotechnology

Flagship Biosciences, Inc.

Broomfield, CO · CIK 0001733718

Offering snapshot reported Apr 18, 2024 · SEC filing

Reported sold
$5M
Offering amount: $6.37M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 10, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 18, 2024Initial$5,000,000No comparison3SEC filing
Feb 21, 2024Amendment$3,000,000$1,500,000vs Dec 14, 20233SEC filing
Dec 14, 2023Initial$1,500,000No comparison3SEC filing
Sep 9, 2022Initial$15,285,339No comparison3SEC filing
Jul 9, 2018Initial$2,500,000No comparison10SEC filing
Mar 16, 2018Initial$1,000,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-510950

Source: Form D, filed Apr 18, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fisher Aaron Director
Gary Clark Director
Nancy Gillett Director
Herb Hooper Director
Trevor Johnson Director, Executive
Paul Kirchgraber Director
Joe Kruger Executive
Holger Lange Executive
L. Dean Northey Executive
Dean Northey Executive
Bill Snider Director
William Snider Director
Gregory K. Tucker Director
Tom Turi Director, Executive
G. David Young Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11800 Ridge Parkway Suite 450
Broomfield, CO, 80021